Delta Asia International Corporation (TPEX:6762)
220.50
0.00 (0.00%)
Aug 15, 2025, 1:01 PM CST
Delta Asia International Revenue
Delta Asia International had revenue of 195.12M TWD in the quarter ending June 30, 2025, with 41.74% growth. This brings the company's revenue in the last twelve months to 701.30M, up 55.79% year-over-year. In the year 2024, Delta Asia International had annual revenue of 580.51M with 14.27% growth.
Revenue (ttm)
701.30M
Revenue Growth
+55.79%
P/S Ratio
11.05
Revenue / Employee
3.83M
Employees
183
Market Cap
7.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 580.51M | 72.49M | 14.27% |
Dec 31, 2023 | 508.02M | 45.05M | 9.73% |
Dec 31, 2022 | 462.97M | -68.34M | -12.86% |
Dec 31, 2021 | 531.32M | -23.00M | -4.15% |
Dec 31, 2020 | 554.31M | 170.94M | 44.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Lumosa Therapeutics | 37.25M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |